glp-1 in canada Health approves first pill for high-risk type 2 diabetes patients Market Intelligence Report: Antidiabetic Drugs,

Further dose increases of 2.5 mg can be considered at intervals of at least 4 weeks, up to a maximum of 15 mg weekly, based on individual response and tolerability

NICE guidance (NG28) recommends considering GLP-1 receptor agonists for adults with type 2 diabetes when glycaemic targets are not achieved with other therapies, particularly in those with established cardiovascular disease or at high cardiovascular risk

What the Promotional Video Says This is the section worth reading closely, because the gap between the video and the official site is the actual story here - not a hidden flaw, but useful information for judging the product on its own terms

With the knowledge of miRNA profiles, we can personalize treatment plans to ensure that each patient gets the most out of it with the least amount of danger

However, the full effect on HbA1cthe standard measure of long-term glucose controltypically requires 8 to 12 weeks to become apparent